Drugs / Duloxetine hydrochloride enteric-coated capsules
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05018013 Comparator | Aug 2021 → Aug 2022 | major depressive disorder | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Duloxetine hydrochloride enteric-coated capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05018013 ↗ |